drug pricing reform Archive

Biden Tax Fairness: Double Taxation
March 13, 2023
No Comments
TweetShareSharePin0 Shares As President Biden pointed out in his State of the Union address to raucous applause, “I think a lot of you at home agree with me that our present tax system is simply unfair.” Two often overlooked aspects of unfairness in our tax code are complexity and double taxation, which would be made

Biden Tax Hike Proposals Live on After the Inflation Reduction Act
October 10, 2022
No Comments
TweetShareSharePin0 Shares Over the past two years, policymakers and taxpayers have grappled with proposals to increase taxes as ideas introduced in the 2020 presidential campaign were transformed into legislation. This effort culminated in August with the enactment of the Inflation Reduction Act. While many of the tax increases considered over the last two years were

Lawmakers Revive Prescription Drug Pricing Policies, 1,900% Excise Tax
July 11, 2022
No Comments
TweetShareSharePin0 Shares While the bulk of the proposed tax increases and spending programs remain under debate, Democratic lawmakers have reportedly agreed on prescription drug pricing provisions as a starting point for a revived Build Back Better package. Advocates of the drug pricing policy argue it would allow Medicare to negotiate prescription drug prices, but it amounts

Biden Prescription Drug Pricing & Price Controls
April 20, 2022
No Comments
TweetShareSharePin0 Shares A centerpiece of the Build Back Better Act (BBBA) as passed by the House last year was drug pricing legislation, which could be included in the next version of the BBBA, now rebranded as an inflation-control, climate, and deficit-reduction bill. While headline inflation is at an alarming rate, with the most recent 12-month

Don’t Copy European Drug Pricing Policies that Reduced R&D Innovation
September 9, 2021
No Comments
TweetShareSharePin0 Shares U.S. companies succeed and maintain their success by engaging in research & development (R&D) that results in innovative products and services reaching customers around the world. But U.S. policies that create tax or regulatory penalties, such as the drug pricing and excise tax proposal lawmakers are considering in the reconciliation package, can curtail